# EDGAR Filing Document

**Accession Number:** 0001145986
**File Stem:** 0001171843-26-003109
**Filing Date:** 2026-5
**Character Count:** 30734
**Document Hash:** ff6b5550ee4d2ab2e2c7bcd85ffc4ee3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-26-003109.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0001171843-26-003109

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260507

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260507

**DATE AS OF CHANGE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ASPEN AEROGELS INC
- **CENTRAL INDEX KEY:** 0001145986
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 043559972
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36481
- **FILM NUMBER:** 26950681

**BUSINESS ADDRESS:**
- **STREET 1:** 30 FORBES ROAD
- **STREET 2:** BUILDING B
- **CITY:** NORTHBOROUGH
- **STATE:** MA
- **ZIP:** 01532
- **BUSINESS PHONE:** 5086911111

**MAIL ADDRESS:**
- **STREET 1:** 30 FORBES ROAD
- **STREET 2:** BUILDING B
- **CITY:** NORTHBOROUGH
- **STATE:** MA
- **ZIP:** 01532

?xml version='1.0' encoding='ASCII'? Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): May 7, 2026
_______________________________

### ASPEN AEROGELS, INC.

#### (Exact name of registrant as specified in its charter)
_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36481** | **04-3559972** |
| **(State or Other Jurisdiction of Incorporation)** | **(Commission File Number)** | **(I.R.S. Employer Identification No.)** |

---

---

| | |
|:---|:---|
| **30 Forbes Road, Building B<br>Northborough, Massachusetts** | **01532** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

#### Registrant's Telephone Number, Including Area Code: (508) 691-1111

#### (Former name or former address, if changed since last report)
_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

#### Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock | ASPN | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On May 7, 2026, Aspen Aerogels, Inc. announced its financial results for the first quarter of 2026, which ended March 31, 2026, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1.

The information set forth in the press release, except for the information set forth under the headings "Financial Outlook" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

**Item 7.01. Regulation FD Disclosure.**

The information set forth under the headings "Financial Outlook" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **<u>Exhibit Number</u>** | **<u>Description</u>** |
| [99.1](exh_991.htm) | [Press Release issued by Aspen Aerogels, Inc. on May 7, 2026](exh_991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.

The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ASPEN AEROGELS, INC. | ASPEN AEROGELS, INC. |
| Date: May 7, 2026 | By: | <u>/s/ Grant Thoele&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  | Name: | Grant Thoele |
|  | Title: | Chief Financial Officer and Treasurer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Aspen Aerogels, Inc. Reports First Quarter 2026 Financial Results and Recent Business Highlights**

*East Providence manufacturing facility expected to have a staged restart beginning in May*

*$175.6 million quarter-end cash balance; up from $158.6 million at year-end 2025*

*Secured an additional subsea pipeline award to be delivered in Q3 2026*

NORTHBOROUGH, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the first quarter of 2026, and discussed recent business developments.

**First Quarter 2026 Results** 

Total revenue for the first quarter of 2026 was $37.9 million, compared to $78.7 million in the prior year period. During the first quarter of 2026, the Company received $37.6 million in cash from General Motors related to a commercial settlement, of which $3.5 million was recognized as revenue in the first quarter. The remainder has been recorded as deferred revenue, with approximately $4.9 million to be recognized as revenue quarterly through the end of 2027. Thermal barrier segment revenue was $16.3 million, compared to $48.9 million in the prior year period, reflecting a significant reduction in customer demand following changes in regulatory frameworks and incentive programs. Energy Industrial segment revenue was $21.6 million, compared to $29.8 million in the prior year period.

Net loss was $23.7 million, compared to net loss of $301.2 million in the prior year period. Results for the first quarter of 2026 included $0.4 million of restructuring and demobilization costs. Results for the first quarter of 2025 included a $286.6 million impairment charge related to the Company's previously planned second manufacturing facility in Statesboro, Georgia, and $9.8 million in restructuring and demobilization costs. Excluding these items, adjusted net loss was $23.3 million, compared to adjusted net loss of $4.8 million in the prior year period.

Net loss per share was $0.29, compared to net loss per share of $3.67 in the prior year period. Excluding the items described above, adjusted net loss per share was $0.28, compared to adjusted net loss per share of $0.06 in the prior year period.

Adjusted EBITDA was $(12.7) million, compared to $4.9 million in the prior year period.

A reconciliation of non-GAAP financial results to GAAP financial results is provided in the financial schedules that are part of this press release. An explanation of these non-GAAP financial measures is also included below under the heading "Non-GAAP Financial Measures."

**East Providence Manufacturing Facility & Supply Strategy Update**

On April 8, 2026, there was an explosion at Aspen's manufacturing facility in East Providence, Rhode Island. The investigation confirmed that the event occurred in a specific high-temperature oven, resulting in damage to a portion of the facility's production space, requiring the temporary cessation of operations. Aspen is working closely with local, state, and federal agencies to bring the facility back online safely and believes a staged restart of operations will begin in May. The final timeline will depend on the progress of our ongoing mechanical, operational, and safety reviews, as well as obtaining clearance from relevant authorities.

"We are immensely grateful that no employees were seriously injured in the incident. We are also appreciative of the professional work of first responders that night. In the time since, our team has made significant progress. Their work has been instrumental in creating a clear path forward for our East Providence facility," said Don Young, President and CEO. "We also deeply value the close cooperation of East Providence and Rhode Island public officials."

To date, the Company has utilized existing inventory and leveraged the capacity of its external manufacturing facility to help support customer demand.

Mr. Young added, "While it will take time to restore East Providence to its full capabilities, we are working closely with our external manufacturing facility to enhance its production capabilities to support both our Energy Industrial and Thermal Barrier segments. These efforts are intended to develop both near- and long-term supply flexibility, strengthening our operational resilience and reinforcing our commitment to customers."

**Recent Business Highlights & Financial Performance**

* Ended the quarter with cash, cash equivalents, and restricted cash of $175.6 million, compared to $158.6 million at the end of the fourth quarter 2025, highlighted by the receipt of the $37.6 million commercial settlement from General Motors and $15.6 million of debt principal payments

* Awarded a second subsea pipeline project with expected delivery in the third quarter of 2026

* Record quarterly Thermal Barrier revenue from European OEMs

"While the first half of 2026 has been shaped by temporary disruptions and evolving market conditions, we believe the fundamentals of our business are solid," commented Mr. Young. "We are seeing positive market signals across our Energy Industrial platform, alongside growing diversification in our Thermal Barrier segment. As we move through the year, we expect to build momentum and further strengthen our positioning for sustained growth into 2027 and beyond."

**Financial Outlook**

Aspen issues its financial outlook as follows:

* Q2 2026 revenue is expected to range between $40 million and $48 million

* Q2 2026 Net loss is expected to range between $14 million and $20 million

* Q2 2026 Net loss per share is expected to range between $0.17 and $0.24

* Q2 2026 Adjusted EBITDA is expected to range between $(4) million and $(10) million

* FY 2026 Capital Expenditures are expected to be less than $10 million

Grant Thoele, Chief Financial Officer and Treasurer, noted, "Our $175.6 million cash balance and disciplined cost management provide a strong foundation as we navigate our current supply and demand environment. Looking ahead to Q2, we expect increased quarterly revenue and improved profitability. With a healthy balance sheet and a financial framework that supports both resilience and growth, we believe that we remain well-positioned to operate and execute our flexible supply strategy, pursue growth opportunities, and deliver long-term shareholder value."

The Company's Q2 2026 outlook assumes depreciation and amortization of $5.0 million, stock-based compensation expense of $2.5 million, net interest expense of $2.5 million, and diluted weighted average shares outstanding of 82.7 million for the quarter.

A reconciliation of net loss to non-GAAP Adjusted EBITDA for the Q2 2026 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2026, including those related to the staged restart of the East Providence manufacturing facility, operational disruptions, supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

**Conference Call and Webcast Notification**

A conference call with Aspen management to discuss first quarter 2026 results and recent business developments will be held Thursday, May 7, 2026, at 8:30 a.m. EST. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

Shareholders and other interested parties may call +1 (833) 461-5787 (domestic) or +1 (585) 542-9983 (international) and reference Meeting ID "717749648" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com.

Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.

**Non-GAAP Financial Measures**

In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measures included in this press release are Adjusted EBITDA, adjusted net loss and adjusted net loss per share. Management uses these non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.

The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net income (loss), adjusted net loss to net loss and adjusted net loss per share to net loss per share, in each case to the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.

**About Aspen Aerogels, Inc.**

Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

**Special Note Regarding Forward-Looking and Cautionary Statements**

This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's financial outlook for the second quarter of 2026. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's financial outlook for the second quarter of 2026. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's beliefs and expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net income (loss), Adjusted EBITDA, adjusted net loss, adjusted net loss per share and related increases, decreases, trends or timing, including with respect to Aspen's beliefs and expectations about the energy industrial and EV markets; Aspen's target revenue capacity and gross margins; Aspen's efforts to use its external manufacturing facility to meet customer demand; current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the energy industrial and EV markets; beliefs about Aspen's ability to provide and deliver products and services to energy industrial and EV customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's energy industrial and EV opportunities; and the performance and market acceptance of Aspen's products. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: Aspen's ability to resume operations at the East Providence manufacturing facility; the Company's ability to manufacture the full array of its products at the facility and to meet expected customer demand; the Company's ability to mitigate the potential impacts from the operational disruption on the Company's business, operations and financial performance; Aspen's ability to execute its growth plan; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen's ability to create customer or market opportunities for its products; any disruption or inability to achieve expected capacity levels in any of its manufacturing or assembly facilities, including at its external manufacturing facility; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading "Risk Factors" in Aspen's Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission ("SEC") on March 13, 2026, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.

**Investor Relations Contacts**

Neal Baranosky

Phone: (508) 691-1111 x 8

nbaranosky@aerogel.com

Georg Venturatos / Patrick Hall

Gateway Group

Phone: (949) 574-3860

ASPN@gateway-grp.com

---

| | | |
|:---|:---|:---|
| **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** | **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** | **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** |
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
|  | **(In thousands)** | **(In thousands)** |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $173870 | $156857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 1713 | 1713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 36438 | 35270 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 31054 | 38249 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 10896 | 9964 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 253971 | 242053 |
| Property, plant and equipment, net | 93741 | 98400 |
| Assets held for sale | 32569 | 32712 |
| Operating lease right-of-use assets | 17039 | 18014 |
| Finance lease right-of-use assets | 5838 | 6131 |
| Other long-term assets | 7318 | 9369 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $410476 | $406679 |
| **Liabilities and Stockholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $13611 | $13243 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 17967 | 12952 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 36578 | 1259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance obligation for sale and leaseback transactions | 5133 | 4443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 3077 | 3245 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | 1813 | 1768 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long term debt - current portion | 24231 | 25115 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 102410 | 62025 |
| Revolving line of credit | 7061 | 14346 |
| Long term debt | 61244 | 65455 |
| Finance obligation for sale and leaseback transactions long-term | 3220 | 4953 |
| Operating lease liabilities long-term | 20271 | 21138 |
| Finance lease liabilities long-term | 2773 | 3244 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 196979 | 171161 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 213497 | 235518 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $410476 | $406679 |

---

---

| | | |
|:---|:---|:---|
| **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** |
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31,** | **March 31,** |
|  | **2026** | **2025** |
|  | **(In thousands, except**<br>**share and per share data)** | **(In thousands, except**<br>**share and per share data)** |
| Revenue | $37884 | $78723 |
| Cost of revenue | 33608 | 55911 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 4276 | 22812 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 2724 | 4333 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 6668 | 8384 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 15291 | 13034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 427 | 9790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment |  | 286612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 25110 | 322153 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (20834) | (299341) |
| Other income (expense) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (3151) | (1962) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 41 | 1130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (3110) | (832) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss before income taxes | (23944) | (300173) |
| Income tax benefit (expense) | 253 | (1076) |
| Net loss | $(23691) | $(301249) |
| Net loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic and diluted | $(0.29) | $(3.67) |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic and diluted | 82742789 | 82065676 |

---

**Analysis of Cash Flow**

The following table summarizes our cash flows for the periods indicated.

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **March 31,** |
|  | **2026** | **2025** |
|  | **(In thousands)** | **(In thousands)** |
| Net cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $34145 | $5632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (1367) | (12998) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (15765) | (21477) |
| Net increase (decrease) in cash | 17013 | (28843) |
| Cash, cash equivalents and restricted cash at beginning of period | 158570 | 221276 |
| Cash, cash equivalents and restricted cash at end of period | $175583 | $192433 |

---

**Reconciliation of Non-GAAP Financial Measures**

The following table presents a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:

**Reconciliation of Adjusted EBITDA to Net loss**

We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.

For the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31,** | **March 31,** |
|  | **2026** | **2025** |
|  | **(In thousands)** | **(In thousands)** |
| Net loss | $(23691) | $(301249) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5382 | 5793 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2314 | 2073 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense | 3110 | 832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax (benefit) expense | (253) | 1076 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 427 | 9790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment |  | 286612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $(12711) | $4927 |

---

**Other Information**

The following table reconciles net loss and net loss per share to adjusted net loss and adjusted net loss per share for the three months ended March 31, 2026 and 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** |
|  | **Amount** | **Per Share** | **Amount** | **Per Share** |
|  | **(In thousands)** | | **(In thousands)** | |
| Net loss | $(23691) | $(0.29) | $(301249) | $(3.67) |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 427 | 0.01 | 9790 | 0.12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment |  |  | 286612 | 3.49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted net loss | $(23264) | $(0.28) | $(4847) | $(0.06) |

---

For the 2026 second quarter financial outlook:

---

| | | |
|:---|:---|:---|
|  | **Current Outlook** | **Current Outlook** |
|  | **Three Months Ending** | **Three Months Ending** |
|  | **June 30, 2026** | **June 30, 2026** |
|  | **Low** | **High** |
|  | **(In thousands)** | **(In thousands)** |
| Net loss | $(20000) | $(14000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2500 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | 2500 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $(10000) | $(4000) |

---